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ABSTRACT: Enzyme engineering plays a central role in developing
efficient biocatalysts for biotechnology, biomedicine, and life
sciences. Apart from classical rational design and directed evolution
approaches, machine learning methods have been increasingly
applied to find patterns in data that help predict protein structures,
improve enzyme stability, solubility, and function, predict substrate
specificity, and guide rational protein design. In this Perspective, we
analyze the state of the art in databases and methods used for
training and validating predictors in enzyme engineering. We discuss current limitations and challenges which the community is
facing and recent advancements in experimental and theoretical methods that have the potential to address those challenges. We
also present our view on possible future directions for developing the applications to the design of efficient biocatalysts.
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1. INTRODUCTION
Enzyme engineering is the process of customizing new
biocatalysts with improved properties by altering their
constituting sequences of amino acids. Despite the immensity
of possible alterations, this procedure has already yielded
remarkable results in new designs and optimization of enzymes
for chemical and pharmaceutical biosynthesis, regenerative
medicine, food production, waste biodegradation and biosens-
ing.1−4 Enzymes are typically, but not exclusively, engineered
for catalytic activity, substrate specificity, enantioselectivity,
thermodynamic stability, stability in cosolvents, expressibility,
and solubility.
The two established and widely used enzyme engineering
strategies are rational design5,6 and directed evolution.7,8 The
former approach is based on the structural analysis and in-
depth computational modeling of enzymes by accounting for
the physicochemical properties of amino acids and simulating
their interactions with the environment. The latter approach
takes after the natural evolution in using mutagenesis for
iterative production of mutant libraries, which are then
screened for enzyme variants with the desired properties.
These two strategies may naturally complement each other:
e.g., site-directed or saturation mutagenesis may be applied on
the rationally chosen hotspots.9 While both strategies show
remarkable results, they require a substantial amount of
computational and/or experimental effort in each particular
case of a biocatalyst optimization.
Machine learning (ML) is a third approach to designing new
biocatalysts that has been gaining attention in the past few
decades. Unlike the model-driven rational design, this strategy
is data-driven in that it identifies patterns in the existing data to
predict properties of the previously unseen but similar input.
Unlike iterative selecting of the existing mutants in directed
evolution, ML-based design can generate new, previously
unseen but promising variants, based on the patterns in the
collected data. And similarly to the complementarity of the
rational design and directed evolution, ML is being used in
combination with the two.5,10 Its increasing popularity stems
from its spectacular performance in some tasks previously
deemed impossible or extremely hard algorithmically: natural
language processing, handwriting and facial recognition, fraud
and spam detection, web search, etc.11 Recent advances in the
analysis of human genetic variation data in biomedicine and
healthcare further increase the appeal of this approach for the
design of beneficial mutations.12−14
Multiple ML algorithms have already been applied to
enzyme engineering. Some notable examples include random
forests used to predict protein solubility,15 support vector
machines16,17 and decision trees18 to predict enzyme stability
changes upon mutations, K-nearest-neighbor classifiers to
predict enzyme function19 and mechanisms,20 and various
scoring and clustering algorithms for rapid functional sequence
annotation.21,22 The main attractiveness of ML in enzyme
engineering stems from its generalizability: once it is trained on
the known input, called a training set, an ML algorithm can
potentially make predictions about new variants almost
instantly. In contrast, the rational design approach often
requires the construction of a new model, which might take
months of intensive calculations and processing, and the
directed evolution approach will most likely involve months of
intensive experimentation. However, the success of an ML
predictor for previously unseen data crucially depends both on
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the quality of the data used for training and the efficiency of
the underlying algorithm. The great diversity of enzyme
mechanisms, reactions, and experimental conditions presents
the major challenge for applying ML to biocatalyst design due
to necessary strict quality control for data collection and
reporting, difficult standardization of data format, lack of
sizable homogeneous data sets for model training, and slow
new data collection for model testing.
The aim of this Perspective is, therefore, to highlight recent
advances in data collection and algorithm implementation for
ML in enzyme engineering. In particular, we discuss how those
developments are affected by available and upcoming
experimental techniques and recent advances in mathematical
and computational algorithms. We also present our view on the
main challenges and possible course of evolution of the ML
methods for designing efficient biocatalysts. For recent results
and comprehensive articles on ML-guided directed evolution,
Figure 1. Schematic workflow of constructing an ML predictor and associated challenges. Step 1: the data are usually turned into a table format and
split into the training and test parts. Any errors, biases, or imbalances will be translated to the predictor’s performance and, hence, must be
accounted for. Step 2: the predictor is trained on the training data set. For example, a decision boundary is derived that allows classifying future
input based on whether data points are inside or outside the boundary. This is a balancing act between two extremes: explaining noise rather than
fundamental dependencies (overfitting) or failure to account for complex dependencies in the data (underfitting). Step 3: the performance of the
predictor is evaluated based on the test data set. For example, true and false positives and negatives and the associated measures are calculated or
the root mean square error (RMSE) is calculated for continuous labels. The random nature of the initial data split as well as data imbalances might
skew the evaluation, and numerous metrics used for evaluation vary in their robustness to different data skews. Even partial inclusion of the test set
at any stage of ML predictor training is called data contamination and usually invalidates the final evaluation.
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analysis in systems metabolic engineering, implementation of
biocatalysts in systems in the industry, and biosystems design,
we refer our readers to the reviews in refs 10 and 23−25.
2. THE ESSENCE OF MACHINE LEARNING
The essence of most ML algorithms is to find patterns in the
available data. These data usually consist of data points with
several features or descriptors, e.g. enzyme sequences, their
secondary and tertiary structures, substitutions, physicochem-
ical properties of amino acids, etc. That number of features
usually varies from dozens to thousands, rendering the
problem high-dimensional. The two major types of ML are
unsupervised and supervised learning. In unsupervised learning,
the goal is either to compress the high-dimensional data into a
lower number of dimensions or to find data clusters. In
supervised learning (Figure 1), one or several target properties,
such as enzyme activity or stability, are designated as labels,
and the goal is to engineer a predictor that will return labels for
unseen data points on the basis of their descriptors, using a
labeled training data set. Quite often, these two ML types
supervised and unsupervisedare combined, which is called
semisupervised learning. In this article, we mainly focus on
supervised learning, since enzyme engineers typically aim to
improve various enzyme properties.
A schematic workflow of supervised ML algorithms is
presented in Figure 1. The most time-consuming stage is
usually data collection and preparation for feeding to an ML-
based algorithm (step 1). Then the data are split into training
and test subsets: the former is used to fine-tune parameters of
an ML-based predictor (step 2), whereas the latter is used for
final evaluation (step 3). For classification problems with
binary labels or labels from a finite number of options, this
evaluation is usually based on the confusion matrix: the
number of true/false positives and negatives.26 For regression
problems with the labels taking continuous values, the root
mean squared error is usually calculated. In either case, the
final evaluation is performed on the test data set, which is
essential since the ultimate goal is to achieve the predictor’s
generalizability on the data not used for training. For this
reason, in protein engineering, sequence similarities in both
data subsets must thus be accounted for. If some protein family
is overrepresented in the training set, the resulting predictor
might be biased toward discerning patterns valid for this family
only. If some sequences in the test set are too close to the
training set, the final performance evaluation will yield
overoptimistic results.
At the training step 2, fine-tuning a predictor or selecting
among several predictors is also possible, usually by means of
the K-fold validation. In this case, the training data is further
subsplit into K subsets, and the training workflow is repeated K
times with each of the K subsets held out for evaluation and
the remaining K − 1 subsets used for training. The average
performance is then used to navigate in the fine-tuning. The
main challenge of step 2 in any supervised ML training is to
avoid data underfitting (high bias) and overfitting (high
variance). Underf itting occurs when a predictor fails to find
patterns even in the training data: e.g., when a simple linear
model is used to explain nonlinear data dependencies.
Overf itting occurs when the performance of a predictor
diminishes dramatically on the test data set in comparison to
the training set due to learning too much detail and noise
instead of identifying general patterns. Both underfitting and
overfitting may arise due to insufficient data quality: excessive
noise, irrelevant or missing features, data bias, or sparseness.
They can also occur due to poor application of an algorithm:
excessive or insufficient flexibility in parameter selection,
improper training protocol, or contamination of the training
data set with the test data set. In the following sections, we
summarize the state of the art and challenges related to both
databases used for training and applications of ML algorithms
in enzyme engineering.
3. DATABASES RELEVANT TO ENZYME
ENGINEERING
3.1. The State of the Art in Data Accumulation. Since
ML algorithms heavily rely on data, the importance of the data
set quality used for training can hardly be overestimated.
Notable examples of databases often used in enzyme
engineering, along with some pros and cons frequently
reported by their users, are present in Table 1. The most
abundant are databases of protein sequences followed by
databases of protein structures. Protein stability and solubility
are the next two qualities that have routinely been measured
for several decades now. A more challenging task is annotating
catalytic properties of enzymes due to the abundance of reaction
types, mechanisms, cofactors, conditions, wide ranges of
substrate specificities, enantioselectivities, and promiscuities.
However, several excellent databases are addressing this
challenge from various perspectives.
3.2. Current Challenges Related to Databases. In
general, if the sought-for dependence is simply not in the
available data, no amount of new data points will help improve
the quality of an ML predictor. In the case of enzyme
engineering, however, we expect enzymatic functions to be
encoded in the sequences and thus to depend on
physicochemical properties of amino acids; hence, both the
quantity and quality of data in those databases are of
paramount importance for designing an ML predictor. We
note that these databases were mostly gathered without any
ML application in mind, which causes the following problems.
As far as data from a single round of experimentation is
concerned, data sets usually cover from dozens to hundreds of
variants due to resource and time limitations, which is
considered a relatively small sample size in the ML framework.
While combining data from different experiments may partially
resolve the problem of insufficient data, the issues with data
consistency and comparability arise: even when each team’s
data collection is systematic, it is systematic in its own way, and
protocols or consistent dictionaries allowing robust pooling of
data have yet to be developed.38 The lack of established
reporting standards often results in missing or, even worse,
erroneous values for some descriptors, for instance, opposite
signs of the change in some value upon introduction of a
mutation.34 This is further exacerbated by the lack of robust
data analysis protocols, such as those used for curve fitting to
determine melting temperatures or kinetic rate constants,
which often raises doubts about the quality of the reported
estimates. In addition to that, recent advancements in the
methods for experimental sciences may render some previous
results obsolete.
Manual curation certainly helps improve the data quality but
is also not a panacea, since earlier studies revealed several
issues such as misannotations of protein functions and
propagating errors from already disproved results.39 This
necessitates intensive quality control and regular cleanup
procedures, which is no longer implemented for some
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databases, as those are no longer actively maintained. Apart
from manual double-checking, those procedures may also
involve “data tidying” to render data sets ML friendly:
representing data in a table format with features in columns
and observations in rows.40 Following the increasingly popular
FAIR principlesfindable, accessible, interoperable, and
reusable datashould also enhance the ability of machines
to automatically find and use the data.41 More specifically for
enzymes, following the guidelines of the standards for
reporting enzyme data (STRENDA) project should increase
the data quality, especially in heterogeneous databases
collected from multiple sources.42
In addition to the data quality, reporting, and organization
problems outlined above, experimental designs themselves may
become an issue for ML applications. The selection of the
protein test variants is usually skewed toward anticipated best
performers, and negative results are often not reported. This
introduces data biases, which affect the performance of ML-
based predictors, since the available parameter space is not
sampled uniformly.43,44 Those biases in databases relevant to
protein science have only recently started to attract
researchers’ attention45,46 and have yet to be explored and
corrected by the community.
Developing new ML predictors is dramatically boosting the
demand for improving the existing databases and generating
new, more uniform, and representative data sets of higher
quality. The former is obstructed by improving scientific
methods and, consequently, the pressing need for a review and
replication of the results published earlier. Hence, the latter
option becomes more attractive, and in our opinion, several
up-and-coming experimental techniques promising in this
respect have already been presented: (i) next-generation
sequencing, (ii) fluorescence-activated cell sorting, (iii) deep
mutational scanning, and (iv) microfluidics. These techniques
Figure 2. Schematic representation of the methods applicable for collection of robust and reliable data. (top) Next-generation sequencing (NGS)
offers the high-throughput analysis of DNA/RNA sequences in the gigabase range per instrument. Second-generation instruments increased the
throughput and accuracy by massive parallelization of short (100′ bp) DNA fragments reads after amplification. The third-generation (long-read)
methods employ a single-molecule real-time sequencing of long DNA fragments (>1 Mbp). (middle) High-throughput screening (HTS) includes a
wide range of different approaches: (i) liquid handling robotics with average throughput of 104 variants per day, (ii) fluorescence-activated cell
sorting (FACS) enabling screening of up to 108 variants per day, and (iii) microfluidics with the production speed of up to 108 reaction droplets per
day. (bottom) Deep mutational scanning (DMS) coupling high-throughput screening with next-generation sequencing offers a powerful strategy
for comprehensively analyzing sequence−function relationships in enzymes.
ACS Catalysis Perspective
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provide high-throughput data collection and more uniform
sampling of possible combinations in quantities more suitable
for ML.
3.3. Emerging Methods for High-Throughput Data
Collection. Technological advances toward miniaturization,
automation, and parallelization have brought efficient tech-
nologies to the novel generation of experimental research
methods with incomparable throughput (Figure 2). Next-
generation sequencing (NGS) has revolutionized genomic
research, enabled access to fundamental molecular data, and
revealed genomic and transcriptomic signatures.47,48 The
throughput of sequencing in the gigabase range per instrument
run enables sequencing whole human genomes in as little as 1
day. The advent of this ultrahigh-throughput sequencing is
propelling research that was considered impossible only a few
years ago and is becoming widespread in many areas of life
sciences and medical research.49 Multiple commercially
available second-generation instruments offer increased
throughput and accuracy. Recently introduced third-generation
(long-read) methods employing single-molecule real-time50 or
nanopore sequencing51 resolve the limitations of short reads,
such as GC bias or mapping to repetitive elements.
While the advanced sequencing technology provides a large
amount of sequence data, for most of these entries, the
structural and functional annotations are still missing. As the
next step, the development of novel effective experimental
methods is being focused on the collection of functional and
structural information. Liquid handling robotics coupled with
the miniaturization of the reaction chambers (up to 1536-well
plates) has become a common technology for high-throughput
screening of enzymatic reactions. By replacing wells with
microcapillaries, further miniaturization and parallelization are
possible (100000 capillaries per standard-sized plate).52
Although wells and capillaries are conceptually simple, the
assay throughput typically does not exceed 106 variants. Higher
numbers can be analyzed if screening is moved from a solid
support to fluids. Fluorescence-activated cell sorting (FACS) is a
widely available technology enabling screening of up to 108
enzyme variants per day.52,53 FACS requires fluorogenic
substrates to be trapped inside or at the surface of the cell
to link genotype and phenotype. Alternatively, sorting enzymes
encapsulated together with their encoding DNA and a
fluorogenic substrate in hydrogel beads is used.
A different approach to miniaturization relies on in vitro
compartmentalization of libraries and reagents within
surfactant-stabilized micrometer-sized droplets in emulsions.52
The water−oil−water double emulsion droplets serve as the
reaction chamber, which can be sorted by conventional FACS
instruments. The utility of this approach was greatly expanded
by microfluidic technologies. Droplet-based microf luidics
enables the production of large numbers (108) of mono-
disperse droplets at very high rates by a continuous flow on a
chip.52,53 Sophisticated manipulations, such as droplet fusion,
incubation, mixing, splitting, and sorting, are also possible.
Droplet-based microfluidics has become a powerful tool
combining the versatility of traditional microtiter plate
screening with the high throughput achieved by FACS. The
tiny volumes involved reduce the costs of screening a single
clone by as much as million-fold in comparison to automated
microtiter-plate screening.52 Ultrahigh-throughput screening in
microfluidic single water-in-oil droplets has emerged as a new
tool with the potential to identify even very rare events from
the large libraries (with 106−108 clones) at low cost. Screening
of enzyme mutants in picoliter compartments, generated at a
kilohertz speed in microfluidic devices, is coming of age.54
When they are coupled with the next-generation sequencing,
high-throughput assays represent a powerful strategy for
comprehensively analyzing sequence−function relationships
in enzymes.52,55 This approach, called deep mutational scanning
(DMS), links genotype to phenotype without the need for
laborious processes involving protein purification and charac-
terization. During the process, a large library of mutant
sequences is synthesized, followed by selection for expressed
phenotypes. Then sequencing the library before and after the
selection quantifies the fitness of each mutant. DMS thus
provides a rapid and facile method to infer sequence
determinants of protein stability and function.52,56,57 DMS
has been employed as an alternative experimental strategy for
the determination of protein fold. The pairs of sequence
positions with strong positive epistasis are overwhelmingly
close in 3D and can be systematically identified by mutation
scans with sufficient coverage to determine high-resolution
(1.8 Å) three-dimensional structure of a protein.58,59 Still,
several computational and experimental challenges must be
addressed to generalize the use of genetic experiments for
structure determination and application to larger proteins.
4. MACHINE LEARNING APPLICATIONS TO ENZYME
ENGINEERING
4.1. The State of the Art in ML-Aided Biocatalyst
Design. Despite being a relatively new field of study, machine
learning for enzyme engineering has already been applied for
several challenging predictions. In this section, we first
consider predictors aimed at elucidating the structure−
function relationships crucial for enzymes on both sides:
predicting the structure for a known sequence, and predicting
the catalytic activity or substrate specificity for a known
sequence/structure. We then touch upon two other important
properties, namely solubility and stability, especially from the
point of view of amino acid substitutions, which is critical for
successful protein engineering. We then present examples in
another active area of application focused on ML-guided
directed evolution. We conclude this section by providing a
Figure 3. Comparison of decision boundaries for a hypothetical linear
predictor with a more flexible nonlinear predictor. While the flexible
predictor (shaded green area), which could be a neural network, is
better at capturing the patterns in the whole feature space, the linear
predictor (green line) also performs reasonably well, especially locally
in the selected square area. In addition, the linear predictor provides a
much more straightforward interpretation of the coefficients and
easier guidelines in the design of new data points, at least locally.
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short historical excursion on the development of ML-based
predictors for enzymes.
The protein structure prediction is arguably one of the longest-
standing challenges in biochemistry, as the number of resolved
structures is dramatically lagging behind the number of known
sequences. Over 145000 structures have been released in the
Protein Data Bank, but this is still nowhere near over 215
million publicly available protein sequences.28 Nevertheless,
even despite a relatively small data set size in comparison to
millions of data points usually available for this method, deep
neural networks showed most the notable results in the latest
biennial assessment of protein structure prediction methods,
CASP13. The AlphaFold network was trained on the PDB
entries to predict the distances between C-beta atoms of
residues using multiple sequence alignments60 and received the
highest score at the competition. Out of 124 targets, around
two-thirds of AlphaFold predictions had a GDT_TS score
above 50, which is indicative of a topologically correct
structure.61 Despite showing a tremendous improvement on
the CASP12 results, this still indicates enough room for further
improvement of protein structure predictors.
Apart from predicting protein structures, predicting catalytic
activities is another active field of research currently. Computa-
tional methods for the protein function prediction range from
sequence- to structure-based and from gene- to genome- and
interactome-based.62 Several initiatives similar to the CASP
competition have already been proposed to address the
functional annotation of enzymes, namely Enzyme Function
Initiative (EFI), the Computational Bridges to Experiments
initiative (COMBREX), and the Critical Assessment of
Function Annotation community-driven experiment (CAFA).
Certain successful attempts to apply ML to assign enzyme EC
numbers using predicted 3D structures63 or exploiting
sequence similarities64 have already been made. Recently,
deep learning was also applied to predict EC numbers on the
basis of a protein sequence using both sequence-length-
dependent features, such as raw sequence one-hot encoding,
and sequence-length-independent features, such as functional
domain encoding.65 The former type of features introduced
nonuniformity in feature dimensionality, and the authors
presented a framework to perform simultaneously dimension-
ality uniformization, feature selection, and classification model
training. As the validation for their predictor, activities of three
isoforms of glutaminase and five isoforms of Aurora kinases B
were predicted in good correspondence with the experimental
data available. Thus, the large data sets of enzyme structures
and activities accumulated to date already allow using deep
learning in the engineering of catalytic activity. Nevertheless,
the problems with the data sets mentioned earlier are
aggravated in the case of recording enzyme activity profiles
due to both complex nomenclature and the abundance of
possible mechanisms.
A more precise functional prediction is possible by restricting
ML training to a particular family of enzymes, which comes at
the cost of much smaller data sets available for training. This
problem may be tackled by applying high-throughput data
collection methods mentioned in section 3.3. The authors of
the recently released GT-predict66 selected for their analysis
the glycosyltransferase superfamily 1, a group of enzymes with
highly diverse substrates. This diversity, combined with the
high scaffold conservation, increases the importance of subtle
background mutations for the chemical function. Data from
the label-free mass spectroscopy-based assay of 91 substrates
and 54 enzymes derived from the plant Arabidopsis thaliana
were used for functional prediction. The authors trained
sequence-based decision trees, systematically varying combi-
nations of physicochemical properties, e.g. log P, molecular
area, and number/type of nucleophilic groups, and structural
information, e.g. scaffold type and functional groups. The
resulting predictor was successfully tested on four individually
selected gene sequences as well as two complete families of
enzymes from four different organisms, which highlights the
tremendous potential of training ML predictors on the newly
acquired data from high-throughput data collection methods.
However, caution must be taken when extrapolating the results
of this study to other families. It is yet to be seen if a strong
predictor for one family will perform well when it is retrained
on the data for another family.
Predictors of protein solubility usually exploit the eSol
database (Table 1) for the entire ensemble of Escherichia coli
proteins.67 In their recent paper,35 Han and coauthors
considered seven different binary and continuous ML
algorithms: logistic regression, decision tree, support vector
machines, Naive Bayes, conditional random forest, XGboost,
and artificial neural networks. The support vector machine
showed the highest accuracy based on 10-fold cross-validation.
Figure 4. Visible neural networks to model the hierarchical structure and function of a living cell. (a) A conventional neural network translates the
input to output as a black box without any knowledge of system structure. (b) In a visible neural network, input−output translation is based on
prior knowledge. In DCell, gene-disruption genotypes (top) are translated to cell-growth predictions (bottom) through a hierarchy of cell
subsystems (middle). (c) A neural network is embedded in the prior structure using multiple neurons per subsystem. Reproduced with permission
from Ma and co-workers.102 Copyright 2018, Springer Nature.
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Notably, the authors attempted to use generative adversarial
networks to synthesize more data. This is a pair of two neural
networks competing against each other: one learns to generate
artificial examples and the other to distinguish them from real
data. However, due to data scarcity, no independent test set
was used to evaluate the resulting predictor, implying there is a
strong demand for more abundant data sets of protein
solubility. Moreover, a modest best-achieved R2 value of
around 0.4 indicates that there is still ample room for designing
a more reliable continuous predictor of solubility scores.
Another point of view on protein solubility prediction is
studying the effects of individual mutations. The recent
successes in the application of deep mutational scanning to
collect the data on protein solubility changes upon mutations68
are likely to promote the development of more sophisticated
ML-based protein solubility predictors in the nearest future.
Predicting the effects of amino acid substitutions is not only
limited to solubility: stability, substrate specificity, catalytic
activity, and enantioselectivity can also be targeted if sufficient
data are available. Protein stability predictors are perhaps those
with the most abundant data sets of this type available for ML
training (Table 1). The recently released PON-tstab34 stands
out due to the impressive work the authors undertook to
identify major issues with the widely used ProTherm database.
The authors also presented a random forest classifier trained
using 1106 features from the following groups: experimental
conditions, conservation and coevolution scores for mutated
positions, amino acid substitutions and their physicochemical
properties, neighborhood features for 11 positions before and
after substitution sites, and thermodynamic sequence-based
features extracted from ProtDCal.69 PON-tstab is a three-class
predictor (stability increasing, decreasing, unchanged) and
achieved the correct prediction ratio of around 0.5 versus the
value 0.33 for a random predictor. This implies that, even with
a data set of higher quality, predicting protein stability remains
an extremely challenging task.5
Another intriguing application of ML in protein engineering
is to design smart combinatorial libraries for directed protein
evolution.70 This has the potential to both reduce the
experimental effort and improve the exploration of the
sequence space by mutating multiple positions simultaneously.
Moreover, it can approximate the empirical fitness landscape to
suggest a refined set of variants for the next round of screening.
Wu et al.71 used ML-assisted directed evolution to engineer an
enzyme for a new stereodivergent carbon−silicon bond
formation. The authors selected the reaction of phenyldimethyl
silane with ethyl 2-diazopropanoate catalyzed by a putative
nitric oxide dioxygenase from Rhodothermus marinus. They
tested a variety of ML algorithms such as linear and kernel
models, shallow neural networks, and ensemble methods to
improve the enzyme enantioselectivity. The starting enantio-
meric excess (ee) of 76% for the S enantiomer was sequentially
improved to 93% by several rounds of ML-guided evolution
experiments, and a new variant with 79% ee for the R
enantiomer was discovered. The authors also compared two
standard directed evolution approaches with the one assisted
by shallow neural networks. They used 149361 previously
published measurements of a total of 160000 variants from
saturation mutagenesis of protein G domain B1 at four
positions. The ML-guided approach yielded a global optimum
twice as often with a 30% reduction in the number of variants
tested.
A historical perspective on the applications of ML to enzyme
engineering is presented in Table 2. The linear regression and
its variants were often used in the first attempts to obtain data-
driven guidance, whereas lately there is a tendency to apply
artificial neural networks and random forests, in part owing to
the increase in data availability and improving high-throughput
data collection methods (see section 3.3).
4.2. Current Challenges Related to ML-Aided
Methods. One of the main challenges in applications of ML
to enzyme engineering stems from the intrinsic multi-
disciplinarity of the approach. Biochemists, molecular biolo-
gists, mathematicians, and computer scientists have to find a
common language to clarify goals, carry out rigorous analysis
and training, and avoid common pitfalls, wrongful usage of
methods, and misinterpretations. Ready to use software
packages certainly help standardize the training of an ML
algorithm for nonspecialists, but heaping all the available data
and running a range of ML algorithms to select the best
predictor might not be the optimal strategy. The No Free
Lunch theorem85 claims that no single ML method is superior
to others a priori;86 therefore, a thorough understanding of the
data types to be used and problems to be solved is essential in
the development of efficient predictors. The current shift
toward new and more complex ML methods, namely
aggregating several algorithms into hybrid meta-predictors,
hyperparameter optimization with many training subcycles,
feature learning, and the fusion of ML-based and classical
bioinformatics tools in a single predictor, will further challenge
the crosstalk between disciplines necessary for the develop-
ment of efficient and robust predictors in enzyme engineering.
With the continuous growth of ML applications in enzyme
engineering, the need for robust comparison of various
predictors is of growing importance. This comparison is
mainly obstructed by the lack of both standardized protocols
for comparison and new data sets for testing. The lack of
benchmark data sets, discrepancies in the performance
measurements used, inaccurate or insufficient disclosure in
publications, and the difficulty in finding reviewers with
sufficiently broad expertise87 are among the most pressing
issues. Researchers working on some applications with a long
track record in bioinformatics, such as protein structure or
function predictions, have already established several platforms
that can be used for comparison of the ML predictors, i.e.
CASP, CAFA, EFI, and COMBREX mentioned in section 4.1.
Other applications have yet to see similar initiatives as, in our
opinion, at least three key ingredients are necessary: (i) a
sufficiently large community of researchers working on
development of such applications, (ii) a sufficient amount of
new high-quality data being collected regularly, and (iii) a
leader that will take on responsibility and invest time and effort
into coordinating this activity. It is also worth noting that
competitions of this kind are not flawless themselves, as their
appearance led to an unwanted side effect: greater secrecy and
an increased time delay before publishing newly developed
methods due to the competition deadlines, which negatively
affects the speed of knowledge circulation in science.
Moreover, while their participation is welcome, industrial
participants often have a competitive advantage, i.e. access to
private data, and are often not required to make their codes
public.
Finally, the excitement about novel applications of ML to
enzyme engineering seems to put another critical component
of the approach on the back burner. The ultimate goal of
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science is not only to achieve better predictive power but also
to be able to explain the results. Few papers go beyond simple
ROC analysis: e.g., resample cross-validation to estimate its
statistical significance, explore the reasons for weak predictions,
and analyze learning curves. Why does a particular predictor
have a better performance? What features are critical for the
performance of a predictor on a global scale? What ranges for
feature values and what parts of the feature space are most
critical for a particular data point to be classified correctly?
Many articles on the topic lack this kind of analysis, which
limits our understanding of the underlying molecular
principles. In the next section, we touch upon modern trends
in the ML workflow and architecture and also discuss how
interpretable and explainable predictors can possibly provide
some answers to the questions above.
4.3. Emerging Trends in ML-Based Methods for
Enzyme Engineering. With the accumulation of more data
by virtue of the emerging high-throughput experimental
methods, the development of benchmark data sets and unified
performance measurements is only a matter of time. Recently,
an intriguing algorithm based on semisupervised learning has
been presented to allow benchmarking in five different
prediction tasks related to protein engineering, including
secondary structure, fluorescence landscape, and stability
landscape predictions.88 Moreover, as the data generation is
streamlined, a data set from a single experiment is starting to
have the size large enough for training ML algorithms to guide
the design of future experiments, as was the case in the
development of stereodivergent carbon−silicon bond forma-
tion71 and the application of Gaussian processes to the
directed evolution of cytochromes.89
The increase in the available data will prompt more
extensive use of deep neural networks. This approach has
already shown remarkable potential for complex tasks in
genomics and proteomics but still has limited usage in enzyme
engineering due to data scarcity. Sophisticated neural network
architectures, such as recurrent or graph-based neural net-
works, simultaneous training of several types of predictors
(multitasking), combining structurally different input data
(multimodal design), ML-based modeling of data sets
(generative models), and retraining predictors used in one
area by new data from another area (transfer learning) have
only recently been applied in genomics.14 Several exciting
attempts have also recently been made to apply some of those
advanced techniques to proteins: using generative models to
create soluble and functional malate dehydrogenase variants90
or predict mutational effects with high correlation with those
actually observed in 42 high-throughput deep mutational
scanning experiments.91 More data will also allow improving
the existing methods, i.e. learning the optimal architecture of a
predictor from the data (hyperparameter optimization),92
smart aggregation of several predictions from multiple
methods,93 and introducing robust confidence scores for
predictions.94 In enzyme engineering, this new level of
algorithmic complexity will further save time and resources
wasted on validating misleading predictions but will also
require more sophisticated computer architecture, e.g. an
increased use of parallel computing and stochastic training
methods, which have already become standard techniques for
the acceleration of deep neural network training.
With the increase in computational power, the incorporation
of molecular dynamics simulations into ML training will allow
accounting for the dynamics of enzyme molecules in contrast
to predominantly using static features currently. This should
further boost predictive power, since the propensity for
catalysis critically depends on the conformational dynamics
and the kinetics of the underlying processes. We also envisage
the combination of ML models with fundamentally different
types of predictors. The development of hybrid methods
became very successful, for example, in the prediction of
protein stability.5 Moreover, models targeting several proper-
ties of biocatalyst simultaneously, e.g. activity, stability, and
solubility, would dramatically reduce the risk of unsuccessful
laboratory experiments resulting from in silico design of active
but unstable or poorly soluble proteins.
Another noticeable trend in ML is toward interpretable and
explainable predictors.95 Apart from the global importance of
features for ML predictors, feature importance scores
calculated for each input example96,97 may help explain why
a particular prediction was made for each input data point. In
addition to providing mechanistic insights, interpretable
algorithms can aid in smart biocatalyst design. For instance,
instead of simply screening all the possible mutations with an
ML-based tool to improve a target property, researchers can
make use of designing variants on the basis of the structure of a
predictor using adaptive sampling.98 Such an approach favors
predictors whose parameters can provide such guidance: e.g.,
linear predictors over more flexible yet harder to interpret
artificial neural networks (Figure 3). Linear predictors allow
analytical design on the basis of the coefficients;99 in contrast,
sophisticated predictors are usually prone to pathological
behavior, i.e. sudden misclassification after a slight and almost
imperceptible perturbation of input.100
Another promising approach is to use interpretable
architectures of predictors already at the design stage, e.g.
the visible neural networks.101 The design of such networks is
guided by the knowledge of the underlying biological
mechanism, e.g. the choice of layers and the connections
between layers may mimic the hierarchical organization of
transcriptional regulatory factors in the cell nucleus. For
instance, the recently released DCell simulates cellular growth
and allows in silico investigations of the molecular mechanisms
underlying genotype−phenotype associations on the basis of
the analysis of different parts of the neural network (Figure 4).
Since enzymes can also be represented hierarchically on the
basis of the annotation of their secondary, tertiary, and
quaternary structure elements and their interactions, a shift
toward applying interpretable visible neural networks may
provide new insights into the mechanism in addition to better
predictors.
Finally, as the field will be getting more accustomed to ML
tools, more stringent requirements for data collection and
transparent application of statistical methods are to be
expected. This is further encouraged by the pressure from
publishers and grant agencies to make scripts and data sets
publicly available. The next logical step will be the creation of
platforms for rapid exchange and validation of models and
their penetration to user communities.
5. SUMMARY
Here we considered recent advancements of ML in enzyme
engineering. The range of possible applications is extensive:
from predicting protein structures, through improving enzyme
stability, solubility, and functional properties, to guiding
through the vast expanse of combinatorial libraries in directed
evolution experiments. Several databases with millions of
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protein sequences, hundreds of thousands of structures,
thousands of biophysical values, and hundreds of well-
annotated catalytic mechanisms already offer practicable
means for training ML-based predictors. Yet the ML potential
in biocatalyst design is far from being fully explored. The
community has still many challenges to face. The lack of
homogeneous and consistent data sets of high quality for
training and validation, classical data imbalances and biases,
intrinsic multidisciplinarity of the approach, and difficulties in
explaining, interpreting, and comparing the results of
predictors are among some of the most pressing issues
today. Those are now being increasingly appreciated and
addressed due to growing demands and the increasing number
of scientists working in this exciting new domain of enzyme
engineering. Some powerful recent experimental techniques,
namely next-generation sequencing, high-throughput screen-
ing, deep mutational scanning, and microfluidics, already allow
collecting data in larger amounts and of better quality and
consistency. As more data are collected, more advanced ML
methods, such as deep learning, with more involved
implementation will take over, necessitating efficient use of
computing power and memory allocation. The recent develop-
ments in interpretable architectures of artificial neural
networks and feature importance scores may provide insights
into the internal principles leading to better prediction.
Reliable ML tools will provide the best possible starting points
for enzyme engineering. They will also create further research
opportunities for explaining derived models, interpreting their
parameters, and understanding underlying molecular mecha-
nisms, eventually leading to a clearer perception of structure−
function relationships of enzymes.
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